If, as some suspect, alien life forms are not DNA or nucleic acid based, a genome sequencer may be the tool to detecting them.
The molecular diagnostics firm said in an amended prospectus that it plans to offer 1.3 million shares of its common stock at between $6.35 and $6.75 per share.
The multi-analyte Zika virus assay was developed by a Luminex partner, GenArraytion, and is available now for research use only.
The isothermal technology from Cascade Biosystems performs about as well as qPCR and could be used in niche DNA detection applications.
The money from the Massachusetts Life Sciences Center will go toward developing a test that does not require laboratory instrumentation.
NEW YORK (GenomeWeb) – Nanosphere today reported a 38 percent jump in its first quarter revenues, but fell short of the consensus Wall Street estimates on the top and bottom lines.
NEW YORK (GenomeWeb News) – Invetech will support the development and manufacture of Biocartis' multiplex platform for biomarker analysis under an agreement announced today.
NEW YORK (GenomeWeb News) – Axela today announced a development deal to integrate Thermal Gradient's rapid PCR technology into Axela's Flow-Thru Chip automated workflow.
NEW YORK (GenomeWeb News) – Trovagene said in a regulatory filing today that it has entered into a deal with Illumina to evaluate the possible integration of Trovagene's transrenal technology with Illumina's sequencing technology.
NEW YORK (GenomeWeb News) – EnviroLogix today announced an agreement with Douglas Scientific to develop and optimize solutions for high-throughput real-time and endpoint nucleic acid analysis.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.
In Science this week: reduction in bee phylogenetic diversity, and more.